Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have seen no corporate reference to a date that the actual reverse split is going to take place. Does anyone know anything about it?
Nothing has been done to address the FDA and won't be done until all the current financing needs are in place. It will be at least another year, IMHO, before GTHP will be ready with the new app.
LuViva is being sold in many countries now. Canada now has a distributor as well. The long term problem has been an FDA whose lead investigator did not recommend approval of the device and procedure. The lead investigator has been replaced. The company has needed new funding so it could resume its quest for FDA approval. The new lead investigator is a female M.D. with an OB/GYN background. It she isn't in a competitor's pocket, we may get somewhere this time.
They are very open, and I encourage you to attend. Who wouldn't want to attend the first one in seven years?
Non-business issues, from what I gather. I think we'll see the meeting come next week. They need to get the financing done.
Today's meeting was postponed until next week.
Revenues through 7-31-16 about equal total revenues for 2016. It won't make much of a difference for shareholders who bought in before the first reverse split. The next reverse split, and the financing that goes with it, however, might make for an interesting buy....especially if the stock starts to drop again post RS. There won't be many shares out there, and major good or bad news will propel the stock in that respective direction.
You just, pretty much, said it yourself, Ben K. I think shareholders are more than ready for a management group to put Medizone and its shareholders first and not on the back burner somewhere.
Spot on, WIV, as usual. Let's remind ourselves that bringing on experienced leadership will work only when said leadership has Medizone as its primary focus.
Everyone who attended a conference call has heard those questions. I now prefer to hold them until the meeting.
Here's the other issue with the rooms. I called the downtown Hampton Inn and found out there is a multi-level marketing convention being sponsored by a company called DoTerra. 12,000 people are expected to attend.
I suggest that anyone planning to attend the shareholder meeting start their reservations search for hotels ASAP. The usual venues at the airports are booked solid. It just so happens that football season will have begun, and Medizone decided to hold its meeting on the weekend of a home BYU game. UCLA is coming to town, so it's a big one. Available room prices, therefore, have been jacked up.
They may not have had a choice.
Barring EPA approval and/or a merger or some sort, the company was going to have to call for a shareholder meeting at some point. We will defer our conference calls until after the shareholder meeting assessment. Management needs to know, however, that, based on the early conference calls, we had more than enough shares pledged to mandate a shareholder meeting on our own. Everyone who keeps an eye on this board now has access to the bylaws thanks to WIV, a champion of the shareholder. Shareholders need to realize that share compensation, especially those pieces granted without shareholder authorization, was awarded to maintain the status quo and bring no additional experience to the management "team" and the board. Additional board members with experience, it appears, are seen as a risk. Focus on the logic and ethics involved in these decisions. This breach is a protection measure that does not enhance the business prospects of the company. I encourage every shareholder to attend the shareholder meeting in person.
People get busy traveling in the summer, so I will be persistent with my conference calls until we get everyone instructed who attended the first two: this Thursday, July 28, at 6:00 P.M. The call-in number is the same. Momentum is building. That's all I'll say for now....just like the company....except I mean it.
We will have another conference call next Thursday, July 28 at 6:00 P.M. The call-in number will follow.
15 minutes till the conference call begins. The number is good
So far, the phone number for tomorrow night's conference call is good. Call in only if you want to find out how to pledge your shares in favor of a shareholder meeting. Thanks.
Don't forget! Our conference call will take place Thursday (tomorrow) evening at 6:00 EDT. The call-in number is 1-571-317-3112, and the code is 871-259-021# # The announcement of the fourth manufacturer in seven years was not followed by any information concerning the status of the original/current EPA application. Section 409 Sarbanes Oxley. Also, authorized shares are just about gone. Full steam ahead. Please check the message board tomorrow in case of a last minute change to the call-in number. Thanks.
I think enough time has elapsed to go ahead with our third conference call. Let's set it for Thursday, July 21, at 6:00 P.M. EDT. 1-571-317-3112 code: 871-259-021# # This meeting will be different than the first two meetings. I will give a brief overview of what was discussed on prior calls and again list a number of priority questions shareholders need to have answered. Then I am going to ask you to pledge your shares so we can attain the required number of shares to demand a shareholder meeting sometime in November. Why November? It's already mid July, and we have no information. We easily could be sitting here in November with an equal amount of zero information. Fair enough? I will give you the email address to make that pledge during the call.
Still here and watching. We actually might have to have a shareholder meeting earlier rather than later. It is now mid-July, and there remains no updates on the EPA application. Even you long term staunch supporters must be a little miffed at this most recent slap in the face to shareholders.
Refer back to my post 41425. Look up Sarbanes Oxley this time.
Mr. Esposito spends a lot of his time being the CEO of Armune, a private company headquartered in Michigan. The company has been successful developing a new diagnostic test for prostate cancer but, recently, sold off some of the testing rights to another company. Small private companies, just like small public companies, are in constant need of cash and spend a lot of their time trying to raise said cash. How much effort is the BOD of Medizone putting into the promotion of the company and its lead product? I am talking about real, calculated global business plans and not some fly-by-night scheme that falls in and out of one's lap. I repeat that it looks like our two newest board members do not have the time to tend to Medizone, and it looks like we have a third one in Indiana unengaged. The two remaining board members do not have marketing backgrounds. One is a scientist with credentials who invented the lead product, and the other one is a long term keeper of the gate with no defined networking/marketing skills for this industry. If all of us knew absolutely nothing about Medizone and/or its personnel and looked at the above information, what probability of success would we place on it? The perks these people are drawing continue to dilute our holdings. What justifies this level of pay when we aren't seeing the work or the communication proving the existence of the work?
Oh....I'm still here, jack,......just looking around a bit. Here we are at the end of June, and still we have no word on the status of the EPA application. Outside of one area in South America, where hopefully a business plan involving real trials is in place, there doesn't seem to be much going on ANYWHERE. I keep referring back to management and its "advisors" not informing shareholders as to the status of the EPA situation. Everyone should look up Section 409 of the Sarbanes Oxley Act. I'll be back in touch after our 4th of July celebration. Then we'll get the ball rolling again.
I just want to let everyone know that I merely spent last week getting caught up from my trip to Seoul. We're now into mid-June without the slightest word regarding the status of the U.S. application dealing with the company's lead product. I will give shareholders instructions, in a few days, pertaining to our next conference call and how we will proceed.
Oh....I think Zeppo is alive and well and has just returned from a conference in Seoul. Back to work.
This company has a five member board. Two of the members are relatively new appointments. They have plenty of experience, but no authority, and their primary careers are elsewhere. Medizone needs five experienced members along with an engaged and experienced management team. I suggest to you that the right people/company can make all the difference in the world.
Thanks again to everyone for supporting the conference call last night. I am confident we will obtain the needed shares to be pledged toward mandating a shareholder meeting. Okay...what's the next step? I will begin drafting a letter to the board. When it is finished, I will convene another conference call. I need everyone to sit in on that call so we can discuss the letter. You will be given instructions on how to officially pledge your shares, and then I can include our "proof" in the letter to management.
Reminder about the time change for today's conference call: 6:30 P.M. Eastern Daylight Time
I am reminding everyone about tomorrow evening's conference call. I have needed to change the time slightly. We will do it at 6:30 P.M. Eastern Daylight Time. The phone number remains 571-317-3112. The access code is 871-259-021 #. Then you will be asked to hit # one more time, in lieu of a PIN.
Please remember the time change to 6:30 P.M.
Thanks
Zeppo
A shareholder meeting is the only way, right now, to get the ball rolling to ensure the company has a viable board and management team when the EPA runs out of reasons to not approve AS. We don't want this company to go belly-up and have AS picked off by a F500 for "a song". I can't imagine any shareholder in favor of the AS system standing in the way of a meeting.
Happy Friday, everyone. I want to remind you about our next conference call this Tuesday, May 17, at 6:00 P.M. Eastern Daylight Time. It is important that we have first time callers on the call to pledge shares yea or nay for a shareholder meeting sometime in the next 4-8 months. The call-in number is 571-317-3112 Code: 871-259-021-#. Then you will be asked to hit another #.
So now Medizone shareholders, in essence, are paying IR (Pentony) to NOT communicate with them. I reiterate there is no law of secrecy surrounding why shareholders cannot be advised of the status of the EPA application.
I have devised a series of questions I would like management to answer. People who have tuned in to the conference call know what those questions are, because I have read them both times. I have covered them ad nauseum on this board in the past and have merely organized them. Why not try sitting in next Tuesday? I am still in information gathering mode. Results so far have been very promising.
Let's not put the cart before the horse, okay? We need to have another conference call or two to gauge acceptance of establishing a shareholder meeting. Everything from my end will be out in the open and above board. I can't say that there won't be boulders in the road from potential opposition. I am just carrying myself with integrity and will press on. First things first.
I will have my new Zeppo address ready in a day or two and will work on a new conference call for Tuesday, May 17. Just with two conferences calls we have identified half the number of shares needed to mandate a shareholder meeting. Please allow me a few lines to talk about benevolence and doing the right thing. I have run stand alone businesses in my life. Had I been running a business and had Asepticsure dropped in my lap as a new product to which I had no familiarity with it or its potential market, I immediately would have recognized my own deficiencies and would have brought in groups to advise, create, and monitor testing, for starters. Then the analysis on hospital need/demand would have begun, again with the right groups who would oversee regulatory controls. Engaging experts at every turn.....what other choice would I have had to make a success out of a life changing product? Public awareness and demand influence government agencies. Medizone has none of the above that works. We seem to have a management team incapable/unwilling to recognize its own limitations. I am appealing to the supporters here. Yes, we can give it a few more months. We can't, however, give it a few more years under current leadership. I think you all know it but just need to come to grips with it. The Board needs to bring in qualified "partners" at this point to oversee development and help govern. What happens if either one of the two major players, at this point, dies or becomes incapacitated by illness, accident, etc. ?
1/3 of the Titanic passengers survived. I am aiming for a much higher percentage for Medizone shareholders.
Given the momentum seen so far, we could go over the top with only one more conference call. A pattern definitely is developing. It is not inconceivable that we could construct a letter for management by the end of May. I will create my new Zeppo email address next week and post it on our board. We will need it to compile "official" pledges of shares and, hopefully, agree on a recommended time for a shareholder meeting that would meet with everyone's approval. Thanks for joining in yesterday. Your commentary and prescribed timelines were appreciated. I realize that we have major "unknowns" at work right now: the status of the EPA application, the situation in Saudi Arabia, the situation in Canada, and the situation in South America. We can be a bit patient to see what scenes unfold, but, given company history, we also should remember that we can't afford to indefinitely wait it out. Time and, especially, resources are dwindling.
I want to thank everyone who participated in last evening's conference call. We had a combination of new people and people who had attended the first call a couple of weeks ago. The discussion was lively and much appreciated. Agreeing on a timeline for a shareholder meeting seemed to be our most contentious point, and that temporary obstacle is just a huge positive for all concerned. We have acute issues and chronic issues. The acute issues take in all the questions we feel need to be answered about the current state of affairs. The chronic issues deal with the need for a pro-active management system and a board that is capable, willing, and able to actually govern. The first two calls have pledged about 30 million shares for holding a shareholder meeting sometime in the next 3-7 months. Had the first two calls seen pledges of less than 10 million shares, I would have thanked everyone for their time and would have asked you all to reconvene in a year. The momentum toward a shareholder meeting seems to be building, however, so I will press on with, at least, one more conference call. I will make an assumption, given the number of blips we had on the phone line, that some shareholders attended one/both calls but decided to remain silent at this time. That's cool. We're all a bit curious in our own ways. Again, I want to thank all of you who pledged and participated. We're all in this venture together, and we are making progress.
Also, you can refer to post #40946 to get a feel for the first meeting and how it was interpreted. We have about 2 1/2 hours to go.